Live
FierceBiotechSpyre spies another edge for UC ambitions with midstage win for anti-TL1A antibodyClinical OMICsGenetics of How Steroids Are Metabolized Impacts Adverse EventsClinical OMICsCellular Biological Age Test Can Predict Disease Risk and SurvivalFierceBiotechJapan, South Korea challenge the West’s place in research rankings: reportEndpoints NewsCMS seeks to close Medicare negotiation 'loophole'Endpoints NewsFDA plans to keep Makary priorities on trials, China, deputy saysClinical OMICsTwo Women, One Mission: Closing the Gap Between Cancer Science and SurvivalEndpoints NewsTakeda fortifies orexin potential with more Phase 3 dataBioWorldAppointments and advancements for June 15, 2026BioWorldFinancings for June 15, 2026BioWorldIn the clinic for June 15, 2026BioWorldOther news to note for June 15, 2026
FierceBiotech 1. Mai 2026

J&J axes $5B CAR-T dream months after touting best-in-disease efficacy

J&J axes $5B CAR-T dream months after touting best-in-disease efficacy

Original
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.